Triamcinolone Ophthalmic Dosage
Applies to the following strength(s): 40 mg/mL
The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Uveitis
4 mg (100 microliters of 40 mg/mL suspension) with subsequent dosage as needed over the course of treatment
Comments:
-Strict aseptic technique is mandatory.
-The vial should be vigorously shaken for 10 seconds before use.
-Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
-After withdrawal, the suspension should be injected without delay.
-Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.
Uses:
-Treatment of sympathetic ophthalmia
-Treatment of temporal arteritis
-Treatment of uveitis
-Treatment of ocular inflammatory conditions unresponsive to topical
Usual Adult Dose for Temporal Arteritis
4 mg (100 microliters of 40 mg/mL suspension) with subsequent dosage as needed over the course of treatment
Comments:
-Strict aseptic technique is mandatory.
-The vial should be vigorously shaken for 10 seconds before use.
-Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
-After withdrawal, the suspension should be injected without delay.
-Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.
Uses:
-Treatment of sympathetic ophthalmia
-Treatment of temporal arteritis
-Treatment of uveitis
-Treatment of ocular inflammatory conditions unresponsive to topical
Usual Adult Dose for Vitrectomy
1 to 4 mg (25 to 100 microliters of 40 mg/mL suspension) administered intravitreally
Comments:
-Strict aseptic technique is mandatory.
-The vial should be vigorously shaken for 10 seconds before use.
-Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
-After withdrawal, the suspension should be injected without delay.
-Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.
Use: Visualization during vitrectomy
Usual Pediatric Dose for Uveitis
4 mg (100 microliters of 40 mg/mL suspension) with subsequent dosage as needed over the course of treatment
Comments:
-Strict aseptic technique is mandatory.
-The vial should be vigorously shaken for 10 seconds before use.
-Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
-After withdrawal, the suspension should be injected without delay.
-Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.
Uses:
-Treatment of sympathetic ophthalmia
-Treatment of temporal arteritis
-Treatment of uveitis
-Treatment of ocular inflammatory conditions unresponsive to topical
Usual Pediatric Dose for Temporal Arteritis
4 mg (100 microliters of 40 mg/mL suspension) with subsequent dosage as needed over the course of treatment
Comments:
-Strict aseptic technique is mandatory.
-The vial should be vigorously shaken for 10 seconds before use.
-Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
-After withdrawal, the suspension should be injected without delay.
-Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.
Uses:
-Treatment of sympathetic ophthalmia
-Treatment of temporal arteritis
-Treatment of uveitis
-Treatment of ocular inflammatory conditions unresponsive to topical
Usual Pediatric Dose for Vitrectomy
1 to 4 mg (25 to 100 microliters of 40 mg/mL suspension) administered intravitreally
Comments:
-Strict aseptic technique is mandatory.
-The vial should be vigorously shaken for 10 seconds before use.
-Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
-After withdrawal, the suspension should be injected without delay.
-Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.
Use: Visualization during vitrectomy
Renal Dose Adjustments
Renal insufficiency: Use with caution
Liver Dose Adjustments
Data not available
Precautions
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
-The manufacturer product information should be consulted.
Storage requirements:
-Do not freeze.
-Protect from light.
